Bioprocess Containers Market by Type (2D Bags  3D Bags  Tank Liners)  Application (Process Development  Upstream  and Downstream)  End Users (Biopharmaceutical  and Life Science Companies)  and Region - Global Forecast to 2023

Bioprocess Containers Market by Type (2D Bags 3D Bags Tank Liners) Application (Process Development Upstream and Downstream) End Users (Biopharmaceutical and Life Science Companies) and Region - Global Forecast to 2023

MarketsandMarkets | ID: 1524212989994 | Published at: 2018-04-12 | Pages: 105

  • €4.785,63


“Global bioprocess containers market projected to grow at a CAGR of 13.2% during the forecast period”
The global bioprocess containers market is expected to reach USD 1,914.6 million by 2023 from USD 1,030.0 million in 2018, at a CAGR of 13.2%. Growth in this market can be attributed to the increasing demand for biologics, affordability and sustainability of single-use bioprocess technologies, vaccine production using single-use disposable technologies, and the lower risk of cross-contamination. Most of these conventional biomanufacturing products require constant sterilization to eliminate contamination, which increases the overall investments for manufacturers. Hence, transition from conventional equipment to single-use systems results in the frequent growth of this market.
“3D bioprocess containers segment is expected to grow at the fastest rate during the forecast period”
Based on type, bioprocess containers market is segmented in to 2D bioprocess containers, 3D bioprocess containers, and other containers and accessories. The 3D bioprocess containers segment is estimated to register the highest CAGR during the forecast period. The significant reductions in labor cost and the faster batch-turnaround achieved using these containers are the major factor driving their adoption.
“The life sciences R&D companies segment is estimated to grow at a rapid rate during the forecast period”
Based on end user, the bioprocess containers market is segmented into biopharmaceutical companies and life science R&D companies. The life science R&D companies segment is expected to grow at the fastest growth rate during the forecast period. The R&D and manufacturing of biologics and biosimilars are extremely expensive due to the amount of detail necessary to replicate and ensure the validation of biosynthesis of living cells and their components. This factor primarily contributes to the growth of this end user segment.
“Asia is estimated to grow at the highest CAGR during the study period”
Geographically, the bioprocess containers market is dominated by North America, followed by Europe in 2018. The Asian region is estimated to grow at the fastest rate which can be attributed to the significant investments by key market players, increasing government support, developing R&D infrastructure, increasing outsourcing of pharmaceutical manufacturing and R&D, and increasing cell culture distribution. For instance, in May 2017, Merck KGaA established its first joint bioprocess scale-up laboratory with Stelis Biopharma in India.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1 – 62%, Tier 2 – 28%, and Tier 10
• By Designation – C level – 62%, Director level – 21%, and Others – 17%
• By Region – North America – 30%, Europe – 20%, Asia Pacific – 40%, and RoW – 10%

The key players in the bioprocess containers market are Thermo Fisher Scientific (US), Sartorius (Germany), GE Healthcare (US), Merck KGaA (Germany), Danaher Corporation (US), Lonza (Switzerland), Fenner PLC (UK), Meissner (US), Rim Bio (US), and Fluids Control (Argentina).
Research Coverage:
The report analyzes the bioprocess containers market by type, application, end user, and region. Apart from comprehensive geographic & product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output in order to remain successful.
Key benefits of buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the bioprocess containers market
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, expansions, and product launches in the bioprocess containers market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the bioprocess containers market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various bioprocess containers market products across geographies.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the bioprocess containers market.

TABLE OF CONTENTS

1 INTRODUCTION 11

  • 1.1 OBJECTIVES OF THE STUDY 11
  • 1.2 MARKET DEFINITION 11
    • 1.2.1 MARKETS COVERED 12
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY 12
  • 1.3 CURRENCY 13
  • 1.4 LIMITATIONS 13
  • 1.5 STAKEHOLDERS 13
    2 RESEARCH METHODOLOGY 14
  • 2.1 SECONDARY DATA 15
    • 2.1.1 KEY DATA FROM SECONDARY SOURCES 15
  • 2.2 PRIMARY DATA 16
    • 2.2.1 KEY DATA FROM PRIMARY SOURCES 17
  • 2.3 MARKET SIZE ESTIMATION 17
    • 2.3.1 BOTTOM-UP APPROACH 18
    • 2.3.2 TOP-DOWN APPROACH 19
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 20
  • 2.5 ASSUMPTIONS FOR THE STUDY 21
    3 EXECUTIVE SUMMARY 22
    4 PREMIUM INSIGHTS 25
  • 4.1 BIOPROCESS CONTAINERS: MARKET OVERVIEW 25
  • 4.2 GEOGRAPHIC ANALYSIS: BIOPROCESS CONTAINERS MARKET, BY TYPE (2017) 26
  • 4.3 GEOGRAPHICAL SNAPSHOT OF THE BIOPROCESS CONTAINERS MARKET 27
  • 4.4 BIOPROCESS CONTAINERS MARKET, BY END USER 27
    5 MARKET OVERVIEW 28
  • 5.1 INTRODUCTION 28
  • 5.2 MARKET DYNAMICS 28
    • 5.2.1 DRIVERS 29
      • 5.2.1.1 Increasing demand for biologics 29
      • 5.2.1.2 Affordability and sustainability of single-use bioprocess technologies 30
      • 5.2.1.3 Vaccine production using single-use disposable technologies 30
      • 5.2.1.4 Lower risk of cross-contamination 31
    • 5.2.2 RESTRAINTS 31
      • 5.2.2.1 Issues related to leachables and extractables 31
  • 5.2.3 OPPORTUNITIES 32
    • 5.2.3.1 Booming biopharma industry in emerging countries 32
  • 5.2.4 CHALLENGES 33
    • 5.2.4.1 Increasing market consolidation 33
      6 BIOPROCESS CONTAINERS MARKET, BY TYPE 34
  • 6.1 INTRODUCTION 35
  • 6.2 2D BIOPROCESS CONTAINERS 36
  • 6.3 3D BIOPROCESS CONTAINERS 37
  • 6.4 OTHER CONTAINERS & ACCESSORIES 38
    7 BIOPROCESS CONTAINERS MARKET, BY APPLICATION 39
  • 7.1 INTRODUCTION 40
  • 7.2 UPSTREAM PROCESSES 41
  • 7.3 DOWNSTREAM PROCESSES 42
  • 7.4 PROCESS DEVELOPMENT 43
    8 BIOPROCESS CONTAINERS MARKET, BY END USER 44
  • 8.1 INTRODUCTION 45
  • 8.2 BIOPHARMACEUTICAL COMPANIES 46
  • 8.3 LIFE SCIENCE R&D COMPANIES 47
    9 BIOPROCESS CONTAINERS MARKET, BY REGION 48
  • 9.1 INTRODUCTION 49
  • 9.2 NORTH AMERICA 50
    • 9.2.1 US 53
    • 9.2.2 CANADA 55
  • 9.3 EUROPE 57
    • 9.3.1 UK 58
    • 9.3.2 GERMANY 60
    • 9.3.3 FRANCE 61
    • 9.3.4 ITALY 62
    • 9.3.5 ROE 64
  • 9.4 ASIA 65
    • 9.4.1 CHINA 68
    • 9.4.2 JAPAN 69
    • 9.4.3 INDIA 71
    • 9.4.4 REST OF ASIA 72
  • 9.5 ROW 74

10 COMPETITIVE LANDSCAPE 75

  • 10.1 OVERVIEW 75
  • 10.2 MARKET SHARE ANALYSIS, 2016 76
  • 10.3 COMPETITIVE SCENARIO 77
    • 10.3.1 EXPANSIONS 77
    • 10.3.2 PRODUCT LAUNCHES 77
    • 10.3.3 ACQUISITIONS 78
      11 COMPANY PROFILES 79
      (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
  • 11.1 THERMO FISHER SCIENTIFIC 79
  • 11.2 SARTORIUS AG 81
  • 11.3 GE HEALTHCARE 83
  • 11.4 MERCK KGAA 84
  • 11.5 DANAHER 86
  • 11.6 LONZA 88
  • 11.7 FENNER 90
  • 11.8 MEISSNER 92
  • 11.9 RIM BIO 93
  • 11.10 FLUIDSCONTROL 94

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
12 APPENDIX 95

  • 12.1 INSIGHTS FROM INDUSTRY EXPERTS 95
  • 12.2 DISCUSSION GUIDE 96
  • 12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 98
  • 12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 100
  • 12.5 AVAILABLE CUSTOMIZATIONS 102
  • 12.6 RELATED REPORTS 102
  • 12.7 AUTHOR DETAILS 103

LIST OF TABLES

TABLE 1 TYPICAL EXTRACTABLES FOR ACCEPTABLE MATERIALS USED IN DISPOSABLE BIOPROCESS MANUFACTURING SYSTEMS 32
TABLE 2 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 36
TABLE 3 2D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET 36
TABLE 4 2D BIOPROCESS CONTAINERS MARKET, BY REGION, 2016–2023 (USD MILLION) 37
TABLE 5 3D BIOPROCESS CONTAINERS AVAILABLE IN THE MARKET 37
TABLE 6 3D BIOPROCESS CONTAINERS MARKET, BY REGION, 2016–2023 (USD MILLION) 38
TABLE 7 OTHER BIOPROCESS CONTAINERS & ACCESSORIES MARKET,
BY REGION, 2016–2023 (USD MILLION) 38
TABLE 8 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 41
TABLE 9 BIOPROCESS CONTAINERS MARKET FOR UPSTREAM PROCESSES,
BY REGION, 2015–2022 (USD MILLION) 41
TABLE 10 BIOPROCESS CONTAINERS MARKET FOR DOWNSTREAM PROCESSES,
BY REGION, 2016–2023 (USD MILLION) 42
TABLE 11 BIOPROCESS CONTAINERS MARKET FOR PROCESS DEVELOPMENT,
BY REGION, 2016–2023 (USD MILLION) 43
TABLE 12 BIOPROCESS CONTAINERS MARKET, BY END USER, 2016–2023 (USD MILLION) 45
TABLE 13 BIOPROCESS CONTAINERS MARKET FOR BIOPHARMACEUTICAL COMPANIES,
BY REGION, 2016–2023 (USD MILLION) 46
TABLE 14 BIOPROCESS CONTAINERS MARKET FOR LIFE SCIENCE R&D COMPANIES,
BY REGION, 2016–2023 (USD MILLION) 47
TABLE 15 BIOPROCESS CONTAINERS MARKET, BY REGION, 2016–2023 (USD MILLION) 49
TABLE 16 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 52
TABLE 17 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 52
TABLE 18 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 53
TABLE 19 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 53
TABLE 20 US: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 54
TABLE 21 US: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 54
TABLE 22 US: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 55
TABLE 23 CANADA: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 55
TABLE 24 CANADA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 56
TABLE 25 CANADA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 56
TABLE 26 EUROPE: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 57
TABLE 27 EUROPE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 57
TABLE 28 EUROPE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 58
TABLE 29 EUROPE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 58
TABLE 30 UK: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 59
TABLE 31 UK: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 59
TABLE 32 UK: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 59
TABLE 33 GERMANY: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 60
TABLE 34 GERMANY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 60
TABLE 35 GERMANY: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 61
TABLE 36 FRANCE: BIOPROCESS CONTAINERS MARKET, BY TYPE,
2016–2023 (USD MILLION) 61
TABLE 37 FRANCE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 62
TABLE 38 FRANCE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 62
TABLE 39 ITALY: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 63
TABLE 40 ITALY: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 63
TABLE 41 ITALY: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 63
TABLE 42 ROE: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 64
TABLE 43 ROE: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 64
TABLE 44 ROE: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 64
TABLE 45 ASIA: BIOPROCESS CONTAINERS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 67
TABLE 46 ASIA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 67
TABLE 47 ASIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 67
TABLE 48 ASIA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 68
TABLE 49 CHINA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 68
TABLE 50 CHINA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 69
TABLE 51 CHINA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 69
TABLE 52 JAPAN: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 70
TABLE 53 JAPAN: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 70
TABLE 54 JAPAN: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 70
TABLE 55 INDIA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 71
TABLE 56 INDIA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 71
TABLE 57 INDIA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 72
TABLE 58 ROA: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 72
TABLE 59 ROA: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 73
TABLE 60 ROA: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 73
TABLE 61 ROW: BIOPROCESS CONTAINERS MARKET, BY TYPE, 2016–2023 (USD MILLION) 74
TABLE 62 ROW: BIOPROCESS CONTAINERS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 74
TABLE 63 ROW: BIOPROCESS CONTAINERS MARKET, BY END USER,
2016–2023 (USD MILLION) 74


LIST OF FIGURES

FIGURE 1 GLOBAL BIOPROCESS CONTAINERS MARKET 12
FIGURE 2 RESEARCH DESIGN 14
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 16
FIGURE 4 BIOPROCESS CONTAINERS MARKET: BOTTOM-UP APPROACH 18
FIGURE 5 BIOPROCESS CONTAINERS MARKET: TOP-DOWN APPROACH 19
FIGURE 6 DATA TRIANGULATION METHODOLOGY 20
FIGURE 7 BIOPROCESS CONTAINERS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION) 22
FIGURE 8 BIOPROCESS CONTAINERS MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION) 23
FIGURE 9 BIOPROCESS CONTAINERS MARKET, BY END USER, 2018 VS. 2023 (USD BILLION) 23
FIGURE 10 BIOPROCESS CONTAINERS MARKET, BY REGION, 2018 VS. 2023 (USD BILLION) 24
FIGURE 11 INCREASING DEMAND FOR BIOLOGICS—MAJOR FACTOR DRIVING THE GROWTH OF THE BIOPROCESS CONTAINERS MARKET DURING THE FORECAST PERIOD 25
FIGURE 12 2D BIOPROCESS CONTAINERS ACCOUNTED FOR THE LARGEST MARKET SHARE
IN 2017 26
FIGURE 13 ASIA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 27
FIGURE 14 BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE BIOPROCESS CONTAINERS MARKET IN 2023 27
FIGURE 15 BIOPROCESS CONTAINERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 28
FIGURE 16 GLOBAL GERIATRIC POPULATION (≥60 YEARS AGE), 2015 VS. 2030 (MILLION) 29
FIGURE 17 2D BIOPROCESS CONTAINERS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 35
FIGURE 18 UPSTREAM PROCESS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 40
FIGURE 19 BIOPHARMACEUTICAL COMPANIES TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 45
FIGURE 20 BIOPROCESS CONTAINERS MARKET: GEOGRAPHIC ANALYSIS 49
FIGURE 21 NORTH AMERICA: BIOPROCESS CONTAINERS MARKET SNAPSHOT 51
FIGURE 22 ASIA: BIOPROCESS CONTAINERS MARKET SNAPSHOT 66
FIGURE 23 EXPANSIONS WAS THE MOST ADOPTED GROWTH STRATEGY FROM 2015 TO 2018 75
FIGURE 24 SHARES OF TOP COMPANIES IN THE GLOBAL BIOPROCESS CONTAINERS
MARKET 2016 76
FIGURE 25 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 79
FIGURE 26 SARTORIUS: COMPANY SNAPSHOT 81
FIGURE 27 GE HEALTHCARE: COMPANY SNAPSHOT 83
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT 84
FIGURE 29 DANAHER: COMPANY SNAPSHOT 86
FIGURE 30 LONZA: COMPANY SNAPSHOT 88
FIGURE 31 FENNER: COMPANY SNAPSHOT 90

Get in touch!

Looking for sample pages? Or want to speak to someone about discounts?

Please leave your details and we'll get back to you as soon as we can!